Item 2.02. Results of Operations and Financial Condition.
On August 13, 2020, NeuBase Therapeutics, Inc. (the "Company") issued a press
release announcing its financial results for the three and nine month periods
ended June 30, 2020. A copy of the press release is furnished as Exhibit 99.1 to
this Current Report.
In accordance with General Instruction B.2 of Form 8-K, the information in Item
2.02 of this Current Report on Form 8-K shall not be deemed "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liability of that section, and shall not be
incorporated by reference into any registration statement or other document
filed under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
Exhibit Number Description
99.1 Press Release, dated August 13, 2020, Reporting Fiscal Third
Quarter 2020 Financial Results
© Edgar Online, source Glimpses